It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...

Sobriety didn’t restore the old version of me; it allowed me to build a new one from the driftwood of the past,” ...

The findings are similar to an analysis STAT conducted, and raise questions about why UnitedHealth pays its doctors more.

Despite no strong evidence of clinical benefit, microdosing GLP-1s will likely continue as a strategy for some to profit off of the popular drug class.

The FDA's top regulator of medicines has resigned after being accused of using his regulatory authority to harm a former ...

Wes Edwards, chief financial officer of primary and urgent care chain Med First, pulls no punches when it comes to money and ...

Late Friday, Medicare issued its final word on physician payments for 2026. The agency is following through on its earlier ...

Caribou Biosciences said its off-the-shelf CAR-T therapy induced complete and durable remissions in patients with advanced ...

Yesterday, STAT’s Lizzy Lawrence and Adam Feuerstein scored another exclusive: The FDA’s top drug regulator has been placed ...

In a major setback, Uniqure said that the timing of when it can file its Huntington's treatment for FDA approval "is now ...

The Americas is the only region of the world to have stopped endemic transmission of measles. But its victory is on the verge ...